Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic respiratory insufficiency: evaluation, evolution, prognosis]

E Weitzenblum1, A Chaouat, M Faller

  • 1Service de Pneumologie, Hôpital de Hautepierre, Strasbourg.

Bulletin De L'Academie Nationale De Medecine
|November 13, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Nurse practitioners as key actors in pulmonary rehabilitation for chronic obstructive pulmonary disease].

Revue des maladies respiratoires·2022
Same author

Severe forms of COVID-19 among patients with chronic respiratory diseases: be attentive to the severity of the underlying respiratory impairment.

Respiratory medicine and research·2022
Same author

[The role of cardiac magnetic resonance imaging in pulmonary arterial hypertension and chronic thrombo-embolic pulmonary hypertension].

Revue des maladies respiratoires·2022
Same author

[Specific effect of exercise training on depression in COPD patients].

Revue des maladies respiratoires·2021
Same author

[IgG4-Related Disease: A rare cause of severe interstitial lung disease].

Revue des maladies respiratoires·2021
Same author

[Familial pulmonary veno-occlusive disease with a composite biallelic heterozygous EIF2AK4 mutation].

Revue des maladies respiratoires·2020
Same journal

[Advances and perspectives in vascularized composite allotransplantation preservation].

Bulletin de l'Academie nationale de medecine·2025
Same journal

[COVID-19: Neurological manifestations and complications during the acute phase of the disease].

Bulletin de l'Academie nationale de medecine·2024
Same journal

[Role of psychological factors in post-COVID-19 condition].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[From the origin of Sars-CoV-2 to dangerous virology/biology].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Neurological forms of long COVID in adults: Critical approach].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Post-COVID-19 syndrome].

Bulletin de l'Academie nationale de medecine·2023
See all related articles

Chronic respiratory failure (CRF) significantly impacts morbidity and mortality, with COPD as the primary cause. Long-term oxygen therapy improves survival rates for severe CRF patients.

Area of Science:

  • Pulmonology
  • Critical Care Medicine

Context:

  • Chronic respiratory failure (CRF) is a significant cause of death, affecting 60,000 individuals in France annually.
  • Chronic obstructive pulmonary disease (COPD) accounts for 90% of CRF cases, characterized by exertional dyspnea.

Purpose:

  • To define severe CRF and outline its primary cause, COPD.
  • To describe the clinical presentation, diagnostic methods, and major complications of CRF.
  • To analyze prognostic factors and the impact of long-term oxygen therapy (LTOT) on survival rates in CRF patients.

Summary:

  • Severe CRF is defined by PaO2 < 55 mmHg, with COPD being the leading cause.
  • Key complications include acute exacerbations and pulmonary hypertension, leading to potential right heart failure.
  • Prognosis is poor, with 5-year survival at 50% for COPD patients, improved to 60-65% with LTOT.

Related Experiment Videos

Impact:

  • Highlights the critical role of COPD in CRF and the importance of early intervention.
  • Emphasizes the prognostic value of pulmonary function tests, blood gas analysis, and hemodynamic measurements.
  • Underscores the survival benefit of LTOT for severe CRF patients, guiding clinical management and patient care.